Gold Price Climbs Above $4,130 as Middle East Tensions Boost Safe-Haven Demand 
Trump Set to Unveil New Tariffs on Dozens of Countries as Global 10% Duty Nears Expiration 
SpaceX Q2 Earnings on Aug. 4 Set Stage for Historic Insider Share Unlock 
Wistron Opens $700M Texas AI Factory to Build Nvidia GB300 Superchips 
South Korea Q2 GDP Beats Forecasts as AI Chip Exports Drive Growth 
Nike Shifts China Online Sales Strategy to Boost Brand and Fight Local Rivals 
US Stock Exchanges Face Earnings Test as Trading Boom Meets Crypto Competition 
Domino’s Weighs Appeal After Australian Court Rules Workers Were Misled on Pay 
Elon Musk Fuels SpaceX-Tesla Merger Speculation After Earnings Call 
ASEAN Ministers Warn Middle East Conflict Threatens Regional Stability and Energy Security 
Oil Prices Extend Four-Day Rally as U.S.-Iran Conflict and Red Sea Threats Raise Supply Fears 
Samsung Eyes Up to $1.14 Billion Investment in AI Startup Mistral 
US Dollar Climbs to Weekly High as Middle East Tensions Lift Treasury Yields and Safe-Haven Demand 
US Dollar Pauses Rally as Middle East Tensions Support Safe-Haven Demand 
Saudi Oil Tankers Reverse Course as Houthi Threats Disrupt Red Sea Shipping 
Gold Climbs Above $4,000 as Middle East Tensions and Fed Outlook Drive Safe-Haven Demand 
GM Q2 Earnings Beat Estimates as General Motors Raises 2026 Profit Outlook 
Abbott Nutrition said last weekend that it had reopened its Sturgis, Michigan plant to resume the production of baby formula. The company hopes that the nationwide shortage of milk will be addressed once it begins the normal production once again.
Abbott Nutrition was able to open its production facility in Michigan after the U.S. Food and Drug Administration (USFDA) had given it the go-ahead to do so. The permit was granted by the agency after the company met the initial requirements as part of a May 16 consent decree.
According to CNBC, Abbott Nutrition will now restart the production of its EleCare baby formula that has been formulated for children who have difficulties digesting other products. The company will also manufacture its other specialty milk and metabolic formulas for infants.
As the company is now able to begin production again, it is hoping to release the first batch of EleCare milk products by June 20. Currently, Abbott is still working to comply with the guidelines set for the resumption of production for its Similac milk line and other infant formulas.
“We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America,” Abbott’s spokesman said in a statement. “We will ramp production as quickly as we can while meeting all requirements.“
It was noted that the issue with the supply of baby formula began in the early stage of the COVID-19 pandemic. However, the situation got worse when Abbott Nutrition’s production facility in Michigan was ordered to close due to contamination. The plant was shut down in February following reports of illnesses in babies after consuming the company-made milk formulas, and two infants have died.
“The FDA is continuing to work diligently to ensure the safe resumption of production of infant formula at Abbott Nutrition’s Sturgis, Michigan, facility,” the USFDA commented with regards to Abbot’s plant reopening. “The agency expects that the measures and steps it is taking, and the potential for Abbott Nutrition’s Sturgis, Michigan, facility, to safely resume production in the near-term, will mean more and more infant formula is either on the way to or already on store shelves moving forward.”
